Skip to main content
All lobbying filings

JIM MASSIE & PARTNERS, LLC

Lobbying for COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS · Trade association representing the radionuclide and radiopharmaceutical industry.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 17, 2026

Official filing document

 Bills named in this filing 4
  • S 1241
    Sanctioning Russia Act of 2025
  • HR 2548
    Sanctioning Russia Act of 2025
  • HR 2504
    The U.S.-European Nuclear Energy Cooperation Act of 2025
  • HR 8106
    To amend title XIX of the Social Security Act to increase transparency and expand coverage options with respect to home…
 Lobbying activity 2
Energy/Nuclear

Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production Legislation impacting the production and distribution of radiopharmaceuticals S.1241 - Sanctioning Russia Act of 2025 H.R. 2548 - Sanctioning Russia Act of 2025 H.R. 2504 - The U.S. - European Nuclear Energy Cooperation Act H.R. 8106 - To impose sanctions with respect to Rosatom

Trade (domestic/foreign)

Issues related to the impact of tariffs on the availability of industrial and medical isotopes.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem